Allurion Technologies (ALURD) Cash from Financing Activities (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Cash from Financing Activities came in at $2.9 million in Q1 2026, down 80.23% YoY from $14.5 million in Q1 2025, and down 37.65% on a QoQ basis from $4.6 million in Q4 2025.
Allurion Technologies (ALURD) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Cash from Financing Activities data on file, last reported at $2.9 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 80.23% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (down 78.62% YoY) and the FY2025 annual result came in at $19.0 million, down 6.13% from the prior year.
- Cash from Financing Activities fell to $2.9 million in Q1 2026, from $4.6 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $98.9 million in Q3 2023 to a low of -$20.4 million in Q4 2023.
- A 5-year average of $10.8 million and a median of $4.6 million in 2025 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities tumbled 239.4% — and 2025, when it surged 8773.58%.
- Tracing ALURD's Cash from Financing Activities over 5 years: stood at $14.6 million in 2022, then plunged by 239.4% to -$20.4 million in 2023, then jumped by 99.74% to -$53000.0 in 2024, then surged by 8773.58% to $4.6 million in 2025, then slumped by 37.65% to $2.9 million in 2026.
- The last three Cash from Financing Activities figures came in at $2.9 million (Q1 2026), $4.6 million (Q4 2025), and -$55000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 2.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.87 Mn |
| Mar 31, 2026 | 2.87 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | -55,000.00 |
| Sep 30, 2025 | -55,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Mar 31, 2025 | 14.50 Mn |
| Mar 31, 2025 | 14.50 Mn |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | 20.93 Mn |
| Sep 30, 2024 | 20.93 Mn |
| Jun 30, 2024 | -1.06 Mn |
| Jun 30, 2024 | -1.06 Mn |
| Mar 31, 2024 | 387,000.00 |
| Mar 31, 2024 | 387,000.00 |
| Dec 31, 2023 | -20.41 Mn |
| Dec 31, 2023 | -20.41 Mn |